COVID-19 | WHO says it is not yet clear if Omicron variant causes more severe disease

COVID-19 | WHO says it is not yet clear if Omicron variant causes more severe disease

However, the agency reiterated that preliminary evidence suggests there may be a higher risk of…

View More COVID-19 | WHO says it is not yet clear if Omicron variant causes more severe disease
U.K., Germany and Italy detect Omicron coronavirus variant cases

U.K., Germany and Italy detect Omicron coronavirus variant cases

Britain, Germany and Italy detected cases of the new Omicron coronavirus variant on Saturday, November…

View More U.K., Germany and Italy detect Omicron coronavirus variant cases
Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld

Commending the investigators from AIIMS on the BBV152 study published in Lancet Infectious Diseases, Bharat…

View More Bharat Biotech update the efficacy of Covaxin to 65.2% against the Delta variant – ET HealthWorld
Bharat Biotech’s COVAXIN® Phase III data published in The Lancet – ET HealthWorld

Bharat Biotech’s COVAXIN® Phase III data published in The Lancet – ET HealthWorld

Hyderabad, November 12, 2021: Bharat Biotech, a global leader in vaccine development and innovation, announced…

View More Bharat Biotech’s COVAXIN® Phase III data published in The Lancet – ET HealthWorld
Covaxin 77.8% effective against COVID-19 disease in adults, no safety concerns: Lancet study – ET HealthWorld

Covaxin 77.8% effective against COVID-19 disease in adults, no safety concerns: Lancet study – ET HealthWorld

Covaxin Bharat Biotech’s indigenously developed Covaxin is safe and effective against COVID-19 disease, said a…

View More Covaxin 77.8% effective against COVID-19 disease in adults, no safety concerns: Lancet study – ET HealthWorld
Bharat Biotech’s partner seeks Covaxin nod in US for children between 2 and 18 years – ET HealthWorld

Bharat Biotech’s partner seeks Covaxin nod in US for children between 2 and 18 years – ET HealthWorld

Bharat Biotech’s partner in the United States for the Covid-19 vaccine-Ocugen on Friday sought emergency…

View More Bharat Biotech’s partner seeks Covaxin nod in US for children between 2 and 18 years – ET HealthWorld
WHO Emergency Use Listing status will expedite global access and availability of COVAXIN : Dr Krishna Ella – ET HealthWorld

WHO Emergency Use Listing status will expedite global access and availability of COVAXIN : Dr Krishna Ella – ET HealthWorld

Hyderabad: World Health Organisation (WHO) Bharat Biotech‘s Covaxin was granted Emergency Use Listing status for…

View More WHO Emergency Use Listing status will expedite global access and availability of COVAXIN : Dr Krishna Ella – ET HealthWorld
Shelf-life of Covaxin increased to 12 months after additional stability data – ET HealthWorld

Shelf-life of Covaxin increased to 12 months after additional stability data – ET HealthWorld

Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Covaxin shelf-life to upto…

View More Shelf-life of Covaxin increased to 12 months after additional stability data – ET HealthWorld
WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend – ET HealthWorld

WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend – ET HealthWorld

The World Health Organisation on Wednesday said it expects to receive clarifications from Bharat Biotech…

View More WHO says likely to receive clarifications from Bharat Biotech on Covaxin by weekend – ET HealthWorld
WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’ – ET HealthWorld

WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’ – ET HealthWorld

The World Health Organisation’s technical advisory group on Tuesday sought “additional clarifications” from Bharat Biotech…

View More WHO seeks ‘additional clarifications’ from Bharat Biotech for Covaxin to conduct final ‘risk-benefit assessment’ – ET HealthWorld
India committed to supplying COVID-19 vaccines to other nations; exports to begin by year end, says official

India committed to supplying COVID-19 vaccines to other nations; exports to begin by year end, says official

The official, however, added that the supply of vaccines to other nations will have to…

View More India committed to supplying COVID-19 vaccines to other nations; exports to begin by year end, says official
WHO’s advisory group set to meet on October 26 to decide on Covaxin EUL approval – ET HealthWorld

WHO’s advisory group set to meet on October 26 to decide on Covaxin EUL approval – ET HealthWorld

The Technical Advisory Group (TAG) to the World Health Organization (WHO) will meet on Tuesday…

View More WHO’s advisory group set to meet on October 26 to decide on Covaxin EUL approval – ET HealthWorld
We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld

We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld

NEW DELHI: Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said…

View More We are waiting for DCGI approval for children’s Covid-19 vaccine: Bharat Biotech Chairman – ET HealthWorld
Morning Digest: India doesn’t rule out ‘net zero’ commitment at CoP; Over 700 held in J&K ahead of Amit Shah’s visit, and more

Morning Digest: India doesn’t rule out ‘net zero’ commitment at CoP; Over 700 held in J&K ahead of Amit Shah’s visit, and more

India hasn’t entirely ruled out on the possibility of agreeing to a ‘net zero’ target…

View More Morning Digest: India doesn’t rule out ‘net zero’ commitment at CoP; Over 700 held in J&K ahead of Amit Shah’s visit, and more
India’s role as pharmacy of world becomes more entrenched as nation inoculates over 100 cr COVID-19 vaccine doses – ET HealthWorld

India’s role as pharmacy of world becomes more entrenched as nation inoculates over 100 cr COVID-19 vaccine doses – ET HealthWorld

New Delhi: As the country achieved the milestone of vaccinating over 100 crore Indians against…

View More India’s role as pharmacy of world becomes more entrenched as nation inoculates over 100 cr COVID-19 vaccine doses – ET HealthWorld
Morning Digest: Indian team meets Taliban Deputy PM; Trump to launch new social media platform, and more

Morning Digest: Indian team meets Taliban Deputy PM; Trump to launch new social media platform, and more

India joined a 10-nation statement recognising the “new reality” of the Taliban in power in…

View More Morning Digest: Indian team meets Taliban Deputy PM; Trump to launch new social media platform, and more
‘Cannot cut corners’ in approving Covaxin: WHO, seeks more info from Bharat Biotech – ET HealthWorld

‘Cannot cut corners’ in approving Covaxin: WHO, seeks more info from Bharat Biotech – ET HealthWorld

United Nations/Geneva: The World Health Organisation on Monday said it was expecting additional information from…

View More ‘Cannot cut corners’ in approving Covaxin: WHO, seeks more info from Bharat Biotech – ET HealthWorld
WHO to meet next week to consider emergency use listing of India’s Covaxin

WHO to meet next week to consider emergency use listing of India’s Covaxin

Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI to the World Health Organisation…

View More WHO to meet next week to consider emergency use listing of India’s Covaxin
India to procure over 30 crore Covid-19 vaccine doses per month by January: Government sources – ET HealthWorld

India to procure over 30 crore Covid-19 vaccine doses per month by January: Government sources – ET HealthWorld

NEW DELHI: India will have a vaccine capacity of 28 crore doses this month, which…

View More India to procure over 30 crore Covid-19 vaccine doses per month by January: Government sources – ET HealthWorld
Covaxin Junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance? – ET HealthWorld

Covaxin Junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance? – ET HealthWorld

Bharat Biotech is on the threshold of becoming the second Indian vaccine maker to receive…

View More Covaxin Junior: Bharat Biotech’s kids’ vaccine is good news. But why is its vaccine for adults yet to get WHO clearance? – ET HealthWorld